A Phase I Trial of Capecitabine Rapidly Disintegrating Tablets and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas and High Grade Gliomas
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2016
At a glance
- Drugs Capecitabine (Primary)
- Indications Glioma
- Focus Adverse reactions
- Sponsors Roche
- 31 Aug 2018 Biomarkers information updated
- 16 Mar 2012 Actual number of patients changed from 8 to 24 as reported by ClinicalTrials.gov.
- 28 Apr 2011 Planned End Date changed from 1 Apr 2010 to 1 Sep 2013 according to ClinicalTrials.gov record.